Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP2759294

Formulation for percutaneous administration containing Fentanyl and analague thereof

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    21.9.2012
  • EP published:
    1.11.2017
  • EP application number:
    12833553.6
  • Max expiry date:
    20.9.2032
  • Title:
    Formulation for percutaneous administration containing Fentanyl and analague thereof

Timeline

Today
21.9.2012EP application
1.11.2017EP Publication

Owner

  • Name:
    Samyang Biopharmaceuticals Corporation
  • Address:
    263, Yeonji-dong Jongno-gu, 110-725, Seoul, KR

Inventor

  • Name:
    YU, Hyun-Suk
  • Address:
    Gunpo-siGyeonggi-do, KR
  • Name:
    LEE, Young-Moo
  • Address:
    Seoul, KR
  • Name:
    KIM, Hyun-Woo
  • Address:
    Yongin-siGyeonggi-do, KR
  • Name:
    KIM, Hee-Sook
  • Address:
    Asan-siChungnam, KR

Priority

  • Number:
    20110095787
  • Date:
    22.9.2011
  • Country:
    KR

Classification

  • Categories:
    A61K 9/70, A61K 31/4468, A61P 17/00, A61K 47/10, A61K 47/16, A61K 47/22, A61K 31/4535, A61K 47/14

Upload documents